Ví dụ về việc sử dụng Statin use trong Tiếng anh và bản dịch của chúng sang Tiếng việt
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Risk of type 2 diabetes with statin use. .
Serious liver injury from statin use is considered very rare.
All had LDL higher than 70 despite maximum statin use.
Another recent study showed statin use increases the risk of diabetes by 46 per cent.
They had their bloodsugar levels measured twice a year, and their statin use was tracked, too.
Occasionally, statin use could cause an increase in the level of enzymes that signal liver inflammation.
The study authors noted, however,that their research only found an association between statin use and diabetes risk.
More recent findings, published in 2017, found that statin use upped the odds for diabetes by as much as 36 percent.
In this study, statin use before hospital admission was higher in the group with unhealthy eating habits and worse outcome.
The analysis showed that, compared with not using statins, there was a clear link between statin use and a reduced risk of VTE.
Very rarely, high-dose statin use can cause muscle cells to break down(rhabdomyolysis) and release a protein called myoglobin into the bloodstream.
We aimed to establish by a meta-analysis of published andunpublished data whether any relation exists between statin use and development of diabetes….
Statin use has also been linked to memory and thinking problems, which could further compromise older people's ability to function in daily life.
Although the researchers confirmed an increased risk of ischemic stroke, diabetes,and myopathy with statin use, they concluded that the benefits far outweigh the dangers.
More specifically, older people who discontinued statin use had a 46% higher risk of experiencing heart problems and a 26% higher risk of experiencing a vascular event, such as a stroke.
To eliminate this doubt, the authors did a meta-analysis of published and unpublished data in order tofind out whether any relation exists between statin use and development of diabetes.
A particular subgroup of patients for whom the advisability of statin use is unclear are those at high risk for intracerebral hemorrhage(or a stroke caused by bleeding within the brain).
Research on this topic is scarce, which led investigators from Canada to conduct a population-based study on 1.5 million residents in Ontario, Canada,to analyze the link between individual statin use and new-onset diabetes.
They also point out that furtherevidence must validate the findings before guidelines for statin use are expanded to include prevention of VTE, as well as cardiovascular disease.
While many patients benefit greatly from statin use to lower cholesterol and reduce their risk of heart attack, a significant number of patients also experience adverse effects from statins. .
Writing in JAMA Internal Medicine,the researchers note that despite a lack of clear recommendation for statin use in the very elderly, over the last decade or so there has been a large increase in the use of the cholesterol-lowering drugs among the over-80s.
They refer to a survey on medical expenditure in the U.S. that finds statin use for primary cardiovascular prevention among people older than 79 years has risen more than threefold between 1990-2000 and 2011-2012from 8.8 percent to 34.1 percent.
Cerivastatin(INN,[1] brand names: Baycol, Lipobay)is a synthetic member of the class of statins used to lower cholesterol and prevent cardiovascular disease.
Most people who use statin drugs tolerate them quite well.
Patients ages 20-75 years and LDL-C≥190 mg/dl, use high-intensity statin without risk assessment.
For patients with diabetes aged 40-75 years A andgt;75 years B without ASCVD, use moderate-intensity statin in addition to lifestyle therapy.
No statin is approved for use under the age of 10, and statin treatment should generally not be used in type 1 children before this age.
No statin is approved for use under the age of 10 years, and statin treatment should generally not be used in type 1 diabetic children prior to this age.
No statin is approved for use under the age of 10 years, and statin treatment should generally not be used in children with type 1 diabetes prior to this age.